Enantioseparation of DPP-4 Inhibitors on Immobilized Crown Ether-Based Chiral Stationary Phase

Abstract

A group of DPP-4 inhibitors such as alogliptin, linagliptin and saxagliptin were selected for enantioseparation for this study. Crown ether columns contain a chiral crown ether ring as a chiral selector is suitable for the compounds having primary amino groups. Since the selected compounds contain free amino groups, a crown ether column was selected for enantiomeric separation of dipeptidyl peptidase-4 inhibitors. Dipeptidyl peptidase-4 inhibitors are a class of oral hypoglycemics that block dipeptidyl peptidase-4 enzyme and can be used to treat diabetes mellitus type 2. A sensitive HPLC method was developed to separate the enantiomers of each dipeptidyl peptidase-4 inhibitor. Effects of various parameters such as type of solvents, selection of additives, effect of pH and column temperature on chromatographic results were studied. The optimal conditions for the chiral separation of dipeptidyl peptidase-4 inhibitors without any derivatization were investigated.